Shelter Pharma Ltd — Important, 17-06-2026: Company Update

Shelter Pharma has shared its Investor Presentation, detailing the Audited Financial Results for H2 and the full year ended March 31, 2026. The company reported strong FY26 revenue from operations of ₹73.13 Cr and a Net Profit of ₹9.03 Cr. Key highlights include a 44.35% year-on-year revenue growth and a 15% compounded profit after tax growth over three years, maintaining an almost debt-free balance sheet. Looking ahead, Shelter Pharma targets ₹200 Cr in annual revenues by 2030, planning a second manufacturing facility and launching new nutraceutical and herbal products to boost its diversified human and veterinary healthcare portfolio.